24 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
417
NOVEL OXADIAZOLE-BASED SELECTIVE HDAC6 INHIBITORS

Italfarmaco
7
Enhancer of Zeste Homolog 2 inhibitors

Glaxosmithkline
6
Pyridine compounds used as PI3 kinase inhibitors

Teligene
42
Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors

Incyte
232
Substituted tricyclic compounds as FGFR inhibitors

Incyte Holdings
79
Tropomyosin-related kinase (TRK) inhibitors

Genzyme
303
TGF-beta inhibitors

Rigel Pharmaceuticals
4
Azaspiro[4.5] decane derivatives and use thereof

Purdue Pharma
353
Fused pyrroledicarboxamides and their use as pharmaceuticals

Sanofi
4
Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors

Acetylon Pharmaceuticals
110
Heteroaromatic phenylimidazole derivatives as PDE10A enzyme inhibitors

H. Lundbeck
51
Pyridopyrazine derivatives and their use

Zentaris
68
Chemokine receptor antagonists

Abbvie
250
Substituted-quinoxaline-type piperidine compounds and the uses thereof

Purdue Pharma
170
Quinazoline derivatives as a multiplex inhibitor and method for the preparation thereof

Hanmi Pharm.
7
6-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolepyrimidines

Boehringer Ingelheim International
233
Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors

Array Biopharma
20
CGRP receptor antagonists

Merck Sharp & Dohme
184
Inhibitors

Probiodrug
6
Rational design of quinazoline-based irreversible inhibitors of human erythrocyte purine nucleoside phosphorylase.

Arizona State University
7
Biochemical and cellular effects of c-Src kinase-selective pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors.

Parke-Davis Pharmaceutical Research
10
Synthesis and inhibition of Src kinase activity by 7-ethenyl and 7-ethynyl-4-anilino-3-quinolinecarbonitriles.

Wyeth Research
15
3-(3,5-Dimethoxyphenyl)-1,6-naphthyridine-2,7-diamines and related 2-urea derivatives are potent and selective inhibitors of the FGF receptor-1 tyrosine kinase.

University of Auckland
38
6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinases with enhanced antitumor activity.

Wyeth-Ayerst Research